Body Weight Range Research Articles

Population pharmacokinetics of selexipag for dose selection and confirmation in pediatric patients with pulmonary arterial hypertension.

Selexipag is an oral selective prostacyclin receptor agonist approved for the treatment of pulmonary arterial hypertension (PAH) in adults. To date, no treatment targeting the prostacyclin pathway is approved for pediatric patients. Our goal is to identify a pediatric dose regimen that results in comparable exposures to selexipag and its active metabolite JNJ-68006861 as those shown to be efficacious in adult PAH patients. Extrapolation from the population pharmacokinetic (PK) model developed in adults (GRIPHON study; NCT01106014) resulted in the definition of three different pediatric body weight groups (≥9 to <25 kg, ≥25 to <50 kg, and ≥50 kg) with corresponding starting doses (100, 150, and 200 μg twice daily) and maximum allowed doses (800, 1200, and 1600 μg twice daily). The proposed pediatric dose regimen was subsequently tested in a clinical study (NCT03492177), including 63 pediatric PAH patients ≥2 to <18 years of age and a body weight range of 9.9-93.5 kg. The body weight-adjusted dose regimen for selexipag resulted in comparable systemic exposures to selexipag and its active metabolite in pediatric patients as previously observed in adult PAH patients. Updating the adult selexipag population PK model provided overall consistent parameters and confirmed that the PK characteristics of selexipag and its active metabolite were comparable between pediatric and adult patients. The presented selexipag dose regimen for pediatric PAH patients is considered appropriate for continuing the clinical evaluation of the safety and efficacy of selexipag in pediatric patients ≥2 years of age.

Standardization of studies on physical development of children in the Russian Federation

BACKGROUND:The importance of studying the growth and development processes of the child population is due to the significance of the pre-clinical approach aimed at primary disease prevention. AIM:To provide the constituent entities of the Russian Federation with standards for the physical development of children and adolescents aged 7–17years. MATERIAL AND METHODS:An analytical study was conducted, big data from the database “Physical Development of Children, Adolescents, and Youth of the Russian Federation in 2000–2021” were analyzed, containing 395,956observations of physical development (length and body weight indicators) of children, adolescents, and young people living in 49constituent entities of the Russian Federation. Priority was given to research in the constituent entities for which regional standards had never been developed or for which they were developed 15–20years or more ago. As a result, at least 2constituent entities were analyzed in each federal district. Big data processing using machine learning was carried out on the basis of the PostgreSQL database. A web application was created that implemented the functions of tabular display of data, construction of histograms with the ability to select parameters and subsequent data publication on the map of the Russian Federation. RESULTS:In Russia at the beginning of the 21st century, the characteristics of physical development of students living in diffe­rent constituent entities of the Russian Federation were established, which allowed us to talk about the presence of “regional scenarios” that must be taken into account when developing standards. At the age of 15, the range of average values of growth indicators for boys in the constituent entities ranged from 161.70±0.20cm in the Kursk Region to 174.55±0.40cm in the Krasnodar Territory (the difference was 12.85cm, p=0.001), for girls— from 154.60±0.50cm in the Republic of Tyva to 165.69±0.55cm in St.Petersburg (the difference was 11.09cm, p=0.001). The range of body weight of 15-year-old boys in the regions was from 50.17±0.70kg in the Kursk region to 66.00±0.80kg in the Khabarovsk region (difference 15.83kg, p=0.001), girls— from 46.90±0.60kg in the Chelyabinsk region to 58.40±0.70kg in the Khabarovsk region (difference 8.50kg, p=0.001). CONCLUSION:40regional standards for the physical development of the child population have been developed in a standar­dized manner, which allows taking into account regional characteristics and makes it possible to use them in practical healthcare in the constituent entities of the Russian Federation.

Shortcomings, limitations and gaps in physiological roles of extracellular vesicles in obesity.

Extracellular vesicles (EVs) play a crucial role in mediating communication between cells across species and kingdoms. The intercellular communication facilitated by EVs through autocrine and paracrine signalling mechanisms is essential for cell survival, maintaining normal metabolic functions and ensuring overall bodily homeostasis and health. Extracellular vesicles are present in various bodily fluids, such as pleural effusions, plasma, breast milk, amniotic fluid, semen and saliva. Additionally, the generation and release of EVs contribute to the removal of cellular waste. Patients with obesity exhibit a higher release and amount of circulating EVs than individuals with normal weight. This increased EV release in obesity might contribute to the inflammatory state characteristic of this metabolic condition, because higher levels of pro-inflammatory molecules are found within their cargo. However, interpreting results related to EV abundance, cargo and biological actions can be complicated by several factors; these include variations in cell sources, a wide age range (from children to the elderly), a mix of females and males, medication use and health status, a range of body weights (from normal weight to morbid obesity) and differences between in vitro assays using cell lines versus primary cultures. This article addresses the shortcomings, limitations and gaps in knowledge, providing a framework for enhancing our understanding of the physiological effects of EVs on obesity.

Pathological and Hormonal Alterations of the Testis in Balb/C Mice Treated With Spirotetramat Insecticide

Background and Objectives: The side effects of insecticides are undeniable due to their excessive use by farmers. This study aims to investigate the impact of spirotetramat insecticide on pathological and hormonal alteration in BALB/c mice testes. Methods: In this experimental study, 24 adult BALB/c male mice, with a body weight range of 25-30 g, were obtained from the Animal House of Uremia University and examined. Mice were randomly divided into three groups of eight: control, experimental group 1, and experimental group 2. The mice of experimental group 1 received 2.5 mg/kg, and experimental group 2 received 10 mg/kg of spirotetramat. The control group received the same amount of distilled water for 21 days through the mouth by gavage. After this period, the mice were anesthetized and evaluated. Data were analyzed using a 1-way analysis of variance in SPSS version 19 software. Results: The results of the study showed that spirotetramat increased the thickness of the tunica albuginea, the diameter of the seminiferous tubules, the differentiation index of the testis tube, and the spermiogenesis index, but it decreased the thickness of the epithelium of the spermatogenic tubules, the replacement index of active spermatogonia, Leydig cells, and FSH, LH, and testosterone hormone levels. The thickness of interstitial tissue, Sertoli, and lymphocyte cells did not change significantly. Conclusion: By inhibiting the activity of acetyl coenzyme A, spirotetramat insecticide disrupts energy production and prevents the synthesis of lipids in the cells, finally decreasing spermatogenesis in mice.

Spring-assisted posterior vault expansion in children over 2 years of age with craniosynostosis.

This study evaluated spring-assisted posterior vault expansion (SA-PVE) in children aged >2 years with craniosynostosis and signs of high intracranial pressure (ICP). We retrospectively analysed all consecutive patients aged > 2 years and operated with SA-PVEbetween 2018 and 2020 at the Craniofacial Center at Sahlgrenska University Hospital, Sweden. During the procedure, a circumferent occipital bone flap extending below the torcula was created and remained attached to the dura. Intracranial volumes (ICVs) were calculated from computed tomography (CT) images, and demographic data and information regarding symptoms and signs of high ICP were collected. The study included eight patients [Crouzon/Pfeiffer (n = 4), multiple craniosynostosis (n = 3), and secondary synostosis (n = 1)]. Median age at SA-PVE was 3.8 years (range: 2.5-12.8 years), and springs were removed after a median of 5.5 months (range: 2.3-8.3 months). The median operating timewas164min (range: 102-221 min), and estimated blood loss was 4.5 mL/kg body weight (range: 1.4-59.1 mL/kg body weight), with 50% of patients receiving a blood transfusion. The median increase in ICV was 206 cm3 (range: 122-344 cm3) representing an 18.7% increase (range: 7.9-24.1%; p = 0.01). Weobserved no major perioperative complications, and symptoms related to high ICP were improved or absent at clinical follow-up. These results demonstrated that SA-PVE involving creation of a large occipital bone flapincluding the torcula as a safe and effective surgical treatment in children aged >2 years with craniosynostosis and elevated ICP.

271 Does social buffering amongst familiar weaned beef calves mitigate castration stressors?

Abstract Co-mingling of beef feeder calves from multiple sources results in biological and behavioral stressors. This study is part of a project exploring social relationships between individual beef cattle and potential benefits of social buffering during stress events. Here, the specific objective was to explore whether feeder calves form preferential relationships which buffer them from surgical castration pain. Within the experiment, two treatment groups were established: Familiar calves were defined as calves who shared a source farm with two other calves in the pen, and Unfamiliar calves were defined as calves who did not share a source with any other pen-mates. It was hypothesized that Familiar calves would exhibit more lying, fewer pain-related behaviors, and fewer agonistic interactions following surgical castration than Unfamiliar pen-mates. Weaned beef bull calves [n = 102, body weight (BW) range ± SD = 112.95 to 370.10 ± 67.8 kg] from 23 source farms were randomly assigned to home pens, each comprised of three Familiar calves and three Unfamiliar calves. Cameras placed above the pens recorded video from which postural (standing and lying), social (agonistic and bunk displacements) and pain-related behaviors (wound checking and hind leg stamping) were quantified. Cattle were handled through a hydraulic squeeze chute once weekly over four consecutive weeks for data collection and standard processing procedures. On d 14 relative to arrival, calves were surgically castrated with multimodal pain mitigation. During all processing events, calves were marked with livestock paint for behavioral observations. Behavior was observed continuously for 15 min at five different time points (0 h, 1 h, 4 h, 24 h, 48 h) relative to when the last calf returned to the home pen after processing, and researchers were blind to treatment allocation. These time periods corresponded to expected periods when pain was absent and present based on duration of local anesthesia and systemic pain relief. Calf was the experimental unit. For the purpose of this abstract, data from the 48 h periods following d 7 and 14 were analyzed using the PROC GLIMMIX procedure of SAS; the model included treatment (Familiar, Unfamiliar) by week interaction. A P-value of ≤ 0.05 was considered significantly different. Regardless of treatment, preliminary analyses identified decreased lying (P &amp;lt; 0.02) and increased wound checking (P &amp;lt; 0.01) 48h following castration (d 14) when compared with the previous week (d 7). There were no observed differences for hindleg stamping (P = 0.2), agonistic behaviors (P &amp;gt; 0.06) or bunk displacement (P = 0.09). Based on preliminary analyses, we did not observe evidence of social buffering effects on castration stress during the immediate post-surgical period.

Insulin sensitivity and skeletal muscle mitochondrial respiration in Black and White women with obesity.

Non-Hispanic black women (BW) have a greater risk of type 2 diabetes (T2D) and insulin resistance (IR) compared to non-Hispanic white women (WW). The mechanisms leading to these differences are not understood, and it is unclear whether synergistic effects of race and obesity impact disease risk. To understand the interaction of race and weight, hepatic and peripheral IR were compared in WW and BW with and without obesity. Hepatic and peripheral IR was measured by a labeled, hyperinsulinemic-euglycemic clamp in BW (n=32) and WW (n=32) with and without obesity. Measurements of body composition, cardiorespiratory fitness, and skeletal muscle (SM) respiration were completed. Data were analyzed by mixed model ANOVA. Subjects with obesity had greater hepatic and peripheral IR and lower SM respiration (P<0.001). Despite 14% greater insulin (P=0.066), BW tended to have lower peripheral glucose disposal (Rd; P=0.062), which was driven by women without obesity (P=0.002). BW had significantly lower glucose production (P=0.005), hepatic IR (P=0.024), and maximal coupled and uncoupled respiration (P<0.001) than WW. Maximal coupled and uncoupled SM mitochondrial respiration was strongly correlated with peripheral and hepatic IR (P<0.01). While BW without obesity had lower Rd than WW, race and obesity did not synergistically impact peripheral IR. Paradoxically, WW with obesity had greater hepatic IR compared to BW. Relationships between SM respiration and IR persisted across a range of body weight. These data provide support for therapies in BW, like exercise, that improve SM mitochondrial respiration to reduce IR and T2D risk.

A prospective observational study comparing rates of medical instability between adolescents with typical and atypical anorexia nervosa.

Recognition of atypical anorexia nervosa (AAN) has challenged underweight as a defining factor of illness severity in anorexia nervosa (AN). The present study aimed to compare rates of medical instability in adolescents with underweight (AN) and non-underweight (AAN) anorexia nervosa. The study examined assessment data from specialist eating disorder services in the UK between January and December 2022. Participants (n = 205) aged 11-18 years were recruited across eight eating disorder clinics and diagnosed with AN (n = 113) or AAN (n = 92) after clinical assessment. Parameters associated with risk of medical instability were compared between AN and AAN groups, using t tests and regression analysis. Rates of bradycardia and hypotension did not differ significantly between AN and AAN groups (p = 0.239 and p = 0.289). Although white blood cell counts were lower in the AN group, rates of leukopaenia could not be statistically compared as a result of there being too few counts in at least one group. No incidences of hypophosphataemia were found in the sample. A significant regression equation was found for percentage median body mass index, but not rate of weight loss, as a predictor of blood pressure, serum phosphorous and magnesium. Our findings indicate that medical instability occurs across a range of body weights in young people with AN and AAN. Although certain parameters of risk such as blood pressure, serum phosphorous and magnesium may be worsened at lower weight, both AN and AAN are serious mental health conditions that can lead to medical instability.

Model-Informed Development of a Cost-Saving Dosing Regimen for Sacituzumab Govitecan.

The antibody-drug conjugate sacituzumab govitecan is approved for metastatic triple-negative breast cancer and has shown promising results in various other types of cancer. Its costs may limit patient access to this novel effective treatment modality. The purpose of this study was to develop an evidence-based rational dosing regimen that results in targeted drug exposure within the therapeutic range while minimizing financial toxicity, to improve treatment access. Exposure equivalent dosing strategies were developed based on pharmacokinetic modeling and simulation by using the published pharmacokinetic model developed by the license holder. The alternative dose was based on the principle of using complete vials to prevent spillage and on the established non-linear relationship between body weight and systemic exposure. Equivalent exposure compared to the approved dosing regimen of 10 mg/kg was aimed for. Equivalent exposure was conservatively defined as calculated geometric mean ratios within the 0.9-1.11 boundaries for area under the concentration-time curve (AUC), trough concentration (Ctrough) and maximum concentration (Cmax) of the alternative dosing regimen compared to the approved dosing regimen. Since different vial sizes are available for the European Union (EU) and United States (US) market, because body weight distributions differ between these populations, we performed our analysis for both scenarios. Dosing regimens of sacituzumab govitecan for the EU (<50 kg: 400 mg, 50-80 kg: 600 mg, and >80 kg: 800 mg) and US population (<40 kg: 360 mg, 40-65 kg: 540 mg, 65-90 kg: 720 mg, and >90 kg: 900 mg) were developed, based on weight bands. The geometric mean ratios for all pharmacokinetic outcomes were within the predefined equivalence boundaries, while the quantity of drug used was 21.5% and 19.0% lower for the EU and US scenarios, respectively. With the alternative dosing proposal, an approximately 20% reduction in drug expenses for sacituzumab govitecan can be realized while maintaining an equivalent and more evenly distributed exposure throughout the body weight range, without notable increases in pharmacokinetic variability.

PSIV-21 Ileal digestibility of amino acids in feed ingredients for 22-, 56-, and 87-kilogram pigs

Abstract The objective of the present study was to test the hypothesis that the apparent ileal digestibility (AID) of amino acids (AA) in feed ingredients is not constant in pigs with 3 different body weights (BW). Eight pigs with initial BW of 22.2 ± 1.2 kg cannulated at the distal ileum were used. Two experimental diets contained corn distillers dried grains with solubles (DDGS) and soybean meal-wheat mixture (SBM-W; 70% soybean meal + 30% wheat) as the sole source of nitrogen, respectively. The diets were assigned to the animals in a 2-period cross-over design. Each period consisted of a 5-d adaptation period and a 2-d ileal digesta collection period. The animals, diets, and experimental design for 50 kg pigs (initial BW = 55.6 ± 3.3 kg) and 80 kg pigs (initial BW = 86.9 ± 5.1 kg) were identical to those used for 22 kg pigs. Orthogonal polynomial contrasts were used to determine the effect of ingredient type (corn DDGS or SBMM) and BW of pigs (from 22 to 87 kg) and the interaction between these 2 main effects. The AID of crude protein, lysine, and methionine in both corn DDGS and SBM-W linearly or quadratically increased (P &amp;lt; 0.05) with an increase in pig BW. An interaction between ingredient type and linear effect of BW was observed (P &amp;lt; 0.05) in histidine, isoleucine, leucine, phenylalanine, threonine, and valine. Specifically, a linear increase in AID of these AA with increasing BW of pigs was greater in SBM-W compared with corn DDGS. In conclusion, the AID values of most AA differed between the BW range of 22 to 87 kg, and these patterns varied among different ingredients.

A preliminary study of ecosmart intra venous system on patients’ comfort

Intravenous fluid therapy may cause discomfort to patients most of the time. More research and innovation are needed to develop infusion devices to provide a more comfortable feeling for patients receiving the therapy. This preliminary study analyzed the effect of economical and smart (ecosmart) infusion systems on comfort in healthy adults. The one-group post-test-only design was used in this pre-experimental investigation. A range of ages, gender, body weight, body temperature, and normal blood pressure selected participants. An independently created, valid, and reliable tool was used to measure comfort. Data analysis employed a t-test on a single sample. Fifteen nursing students are participating as sampling objects. The average comfort score for the study's participants was 11.2 (SD = 2.5967; p &lt; 0.05). The result indicates that the participants are at ease using the ecosmart system. The respondents' sense of comfort related to the instrument showed comfort or relaxation.&#x0D; Keywords: Nursing care; ecosmart; comfort; patient-centered care; hospital; fluid therapy

Interpreting hydroxychloroquine blood levels for medication non-adherence: a pharmacokinetic study

ObjectiveCharacterise the relationship between hydroxychloroquine (HCQ) blood levels and the number of missed doses, accounting for dosage, dose timing and the large variability in pharmacokinetics (PK) between patients.MethodsWe externally validated...

Lactation suppression effect of aqueous seed extract of Aframomum melengueta on female albino rats

Background and aims: Alligator pepper, a dietary spice used as food flavor enhancer is a common ingredient in pepper soup, a spicy delight in most parts of West Africa and possesses both medicinal and nutritive properties. Despite the well documented benefits of breastfeeding for mothers and infants, there are a variety of medical situations for which breastfeeding is contraindicated. Therefore, lactation suppression might be indicated for the best interest of the mother and/or infant. This study was undertaken to investigate the Lactation suppression effect of aqueous seed extract of Aframomum Melengueta on female albino rats. Methodology: Thirty (30) adult female albino rats weighing 160 to 200 g were used for the study while eighteen (18) albino mice of body weights (b.w.) range of 25 g to 30 g were used for the preliminary acute toxicity test. Male rats were introduced into the female rat cages of groups II-V within 12h at the expected estrous phase for mating and withdrawn thereafter. Groups I, II and III were orally administered distilled water only, while Groups IV and V received oral doses of 5 µg/kg b.w. Carbagoline and 3,000 mg/kg b.w. aqueous seed extract of Aframomum melegueta respectively 24 hours postpartum once daily by oral gavage for 3 days. Results: LD50 determination revealed no death was recorded among the animals up to 5000 mg extract/kg body weight. Study indicates that Aframomum melengueta extract elicited significant reduction of prolactin with corresponding increase in estrogen and progesterone in postpartum animals. Histological sections of the mammary gland show extensive fibrosis and congested ducts lobular units within the tissue stroma of the mammary gland of Aframomum melengueta treated animals. Conclusion: The results confirms a positive lactation suppression effect of aqueous seed extract of Aframomum Melengueta on postpartum lactating female albino rats

A randomized, placebo-controlled crossover trial to assess the influence of body weight on aspirin-triggered specialized pro-resolving mediators: Protocol for the DISCOVER Study.

Low-dose aspirin is ineffective for primary prevention of cardiovascular events in people with body weight greater than 70kg. While the prevalent explanation for this is reduced platelet cyclooxygenase-1 (COX-1) inhibition at higher body weights, supporting data are limited, thereby demanding further investigation of the reason(s) underlying this observation. We propose that aspirin-mediated cyclooxygenase-2 (COX-2) acetylation and the resulting synthesis of 15-epi-lipoxin A4, a specialized pro-resolving mediator, is suboptimal in higher weight individuals, which may contribute to the clinical trial findings. To test this hypothesis, we are conducting a double-blind, placebo-controlled, randomized, mechanistic crossover trial. Healthy men and women exhibiting a wide range of body weights take 81mg aspirin and 325mg aspirin for 3 weeks each, following 3-week placebo run-in and wash-out phases. Our target sample size is 90 subjects, with a minimum of 72 completing all visits estimated to be necessary to achieve power adequate to test our primary hypothesis. Our primary endpoint is the difference in change in plasma 15-epi-lipoxin A4 occurring with each dose of aspirin. Secondary endpoints include lipid mediator profiles, serum bioactive lipid profiles, and other endpoints involved in the resolution of vascular inflammation. Study enrollment began in November 2021 and is ongoing. The results of this study will improve our understanding of the mechanisms underlying aspirin's role(s) in the prevention of adverse cardiovascular outcomes. They may also lead to additional studies with the potential to inform dosing strategies for patients based on body weight.

P765 A Novel Monoclonal Antibody Drug Candidate SPY001 Targeting Integrin ɑ4β7 for the Treatment of IBD Demonstrates Prolonged Half-Life in Non-Human Primates

Abstract Background Background: Antagonism of the interaction between the cellular adhesion integrin ɑ4β7 and endothelial ligand mucosal addressin cell-adhesion molecule-1 (MAdCAM-1) has proven to be relatively safe and effective in the treatment for Crohn’s disease (CD) and ulcerative colitis (UC). Additional benefit may be gained from an ɑ4β7 antagonist given via the subcutaneous (SC) route at extended intervals (eg, every 8 to 12 weeks) during maintenance therapy. Methods The humanized monoclonal IgG1 antibody SPY001 binds to the same ɑ4β7 epitope as vedolizumab and includes a YTE modification within the Fc region to increase its serum half-life via increased affinity for the neonatal Fc receptor (FcRn), thereby favoring recycling into the circulation over degradation. Half-life extension was evaluated via pharmacokinetic analysis in Tg276 transgenic mice (hemizygous for human FcRn) following a single intravenous bolus dose of SPY001 (10 mg/kg, 5 mg/kg, 1 mg/kg) and in cynomolgus monkeys following a single bolus dose of SPY001 (150 mg/kg), given by either intravenous (IV) and subcutaneous (SC) administration. PK simulations in humans were based on allometric scaling of SPY001 clearance observed in cynomolgus monkey and conducted in MATLAB. Results In Tg276 mice, the half-life of SPY001 was 10-11 days across all dose cohorts compared to approximately 3 days for vedolizumab. In cynomolgus monkeys, the half-life of SPY001 was 19-23 days following a single IV or SC infusion, a significant increase over the reported half-life of 10 days for vedolizumab in cynomolgus monkeys. Based on allometric scaling of the clearance of SPY001 observed in this study, predictive simulations of SPY001 PK in humans suggested that Q8W-Q12W SC dosing at 300 mg would be able to achieve a C6-wks, induction ≥ 35 mg/mL and Ctrough, ss ≥ 6 mg/mL for simulated patients covering a large range of body weights and albumin concentrations. Conclusion SPY001 is a novel humanized monoclonal IgG1 with an extended half-life over that of vedolizumab in Tg276 mice and cynomolgus monkeys. It offers the potential for effective and safe treatment of CD and UC with the advantage of infrequent SC dosing. Further preclinical and clinical studies are warranted to demonstrate this potential.

The road to virtual control groups and the importance of proper body-weight selection.

Virtual control groups (VCGs) created from historical control data (HCD) can reduce the number of concurrent control group animals needed in regulatory toxicity studies by up to 25%. This study investigates the performance of VCGs on statistical outcomes of body weight development between treatment and control groups in legacy studies. The objective is to reproduce the statistical outcomes of 28-day sub-chronic studies (legacy studies) after replacing the concurrent control group with virtual ones. In rodent toxicity studies initial body weight is used as surrogate for the age of animals. For the assessment of VCG-sampling methods, three different approaches were explored: (i) sam­pling VCGs from the entire HCD, ignoring initial body weight information of the legacy study, (ii) sampling from HCD by matching the legacy study’s initial body weights, and (iii) sampling from HCD with assigned statistical weights derived from legacy study initial body weight information. The ability to reproduce statistical outcomes using virtual controls was determined by the congruence between the legacy study and the HCD weight distribution: regardless of the chosen approach, the ability to reproduce statistical outcomes was high for VCGs when the legacy study’s initial body weight distribution was similar to the HCD’s. When the initial body weight range of the legacy study was at the extreme ends of the HCD’s distribution, the weighted sampling approach was superior. This article demonstrates the importance of proper HCD matching by the legacy study’s initial body weight and discusses conditions to accurately reproduce body weight development.

Effect of age and body condition score on reproductive organ size and sperm parameters in captive male African lion (Panthera leo): Suggesting a prime breeding age

Sexual maturity and body condition are interconnected in many mammals. For non-domestic felids held in human care, the effect of body condition on male fertility has not been studied, although obesity is a recognized problem for many species such as the African lion (Panthera leo) under captive conditions.Here, we assessed body weight, body condition via body condition score (BCS), reproductive organ appearance and size by ultrasonography and semen parameters as a function of age in a large population of captive male lions housed in different facilities in South Africa. Of 59 individuals (age range 2.5–10 years), we rated 21 (36 %) of the males (≥ 4 years) as highly obese (BCS 8–9). Semen collection via urethral catheter was successful in 49 males (83.0 %). Sperm were found in 44 males (74.6 %) across all age groups. Sperm motility and detailed sperm morphology was assessed in 42 and 18 lions, respectively.As expected, body weight and reproductive organ size increased with age, but only the testis size increased in proportion to BCS. Although our data are unbalanced, as older animals (already after five years of age) were more often obese, they suggest an optimum age and body condition for potential fertility with adequate physical maturity in male lions. Physical maturity appeared to be reached between the ages of three and five years, which is later than sexual maturity in male lions.Lions that far exceeded the normal body weight range and had a BCS of 8 or 9 had lower semen quantity and quality. Therefore, male lions in captivity are in prime breeding condition when physical maturity is combined with a BCS < 8.Our data contribute towards interpretation of fertility assessments in managed breeding programs for lions. Ultrasonographic appearance of the reproductive organs, BCS and semen parameters can help to identify and select breeding males.

Papaya Leaf Ethanol Extract Lowers Malondialdehyde Levels, Increases Superoxide Dismutase Levels, and Increases Leydig Cell Count in Male Rats Given High-Intensity Swimming Exercise

Physical activity is any body movement that occurs due to skeletal muscle contractions that require energy expenditure. Overtraining can trigger oxidative stress due to chronic systemic hypoxia, cause an increase in systemic inflammatory response and multiorgan damage, and accelerate the aging process. The aging process is influenced by many factors, one of which is high-intensity swimming exercise which triggers the emergence of free radicals and leads to systemic oxidative stress. High-intensity swimming exercise is associated with an increase in Reactive Oxygen Species (ROS). The Papaya plant is famous for its therapeutic and nutritional properties. Papaya leaves contain secondary metabolites from papaya leaf extract including tannins, saponins, flavonoids, phenolics, and alkaloids. Papaya leaf extract has strong medicinal properties as an antibacterial, antiviral, antitumor, and antioxidant. This research is an experimental study with a post-test-only control group design. The sample in this study were male white rats (Rattus norvegicus) with an age range of 3-4 months with an average body weight range of 180-200 grams. As many as 36 rats were divided into 2 treatment groups. Treatment group 1 (P1) rats were given high-intensity swimming exercise treatment and aquabidest. Treatment group 2 (P2) rats were given high-intensity swimming exercise treatment and papaya leaf extract 60mg / 200g BB orally. Each treatment was carried out for 21 days. The data obtained will be analyzed using an independent sample T-test. The results of this study obtained: (1) the average MDA levels showed that the P1 group (1.02±0.064) was higher than the P2 group (0.86±0.44) with a value of p&lt;0.001; (2) the average SOD level in the P2 group (2.72±0.437) was higher than P1 (1.46±0.288) with p&lt;0.001; (3) the average number of Leydig cells in the P1 group (13.0±5.05) was lower than in the P2 group (30.0±5.05) with p&lt;0.001. This study concluded that papaya leaf ethanol extract in rats was able to reduce MDA levels, increase SOD levels and increase the number of Leydig cells in male rats given high-intensity swimming exercise.

Length-weight Relationship and Condition Factor of Siluriformes Fish Species, Endangered Eutropiichthys vacha, Hamilton (1922) and Endemic Deccan Catfish Rita kuturnee (Sykes, 1839) of Godavari River Andhra Pradesh, South India

Background: The present study of the length-weight relationship and condition factors of two Eutropiichthys vacha and Rita kuturnee, from Godavari River Andhra Pradesh, from the year August 2021 to July 2023 at fortnightly intervals. Methods: The log transformation formula was employed to establish length-weight relationships (LWRs) [3]. The length-weight equation used was W = aLb, in the usual notations. Linear regression of the log-transformed equation, log(W) = log(a) + b log(L), was utilized to calculate the parameters ‘a’ (intercept) and ‘b’ (slope) of the relationship. Result: A total of 1453 specimens of E. vacha and 1273 specimens of R. kuturnee were collected by using gill nets. The collected specimens exhibited a total length range of 10 to 27 cm for E. vacha and 7 to 18.5 cm for R. kuturnee. Correspondingly, the body weight range was recorded as 12 to 140 gm for E. vacha and 8 to 50 gm for R. kuturnee. Statistical analysis revealed a negative allometric growth trend for both males and females of E. vacha and R. kuturnee, with b values ranging from 2.569 to 2.711 for E. vacha and 2.53 to 2.61 for R. kuturnee. The fluctuation in the relative condition factor ranged from 1.06 to 1.09 for E. vacha and 1.001 to 1.12 for R. kuturnee. Furthermore, the overall health conditions of these two species were determined to be favorable.

Moving beyond Weight: A Narrative Review of the Dietary and Lifestyle Management for Reducing Cardiometabolic Risk in Polycystic Ovary Syndrome (PCOS).

Polycystic ovary syndrome (PCOS) is the most common endocrine disorder experienced by women. PCOS is a lifelong condition associated with reproductive, metabolic, and psychological presentations. PCOS is also linked with increased prevalence of cardiometabolic risk factors. While an association between body weight and PCOS has been noted, cardiometabolic risk factors are prevalent in individuals with PCOS across body weights. Currently, no consensus exists as to the most appropriate lifestyle strategy for mitigating cardiometabolic risk in PCOS. A large proportion of the literature is focused on weight loss for individuals with PCOS who are overweight or experience obesity, despite PCOS being prevalent across body sizes. The aim of this narrative review is to assess dietary and lifestyle interventions aimed at reducing cardiometabolic risk in individuals with PCOS across body sizes. A total of 51 articles are included in this review. Overall, randomized controlled trials are limited and most studies focus on weight loss, excluding individuals classified within a healthy body weight range. Studies that modified the dietary pattern without an energy deficit saw improvements in cardiometabolic risk. Thus, less restrictive dietary approaches may be effective at reducing cardiometabolic risk in this population. This review also highlights the need for more sustainable lifestyle interventions that meet the needs of individuals with PCOS of varying body weights.